Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis
Myelodysplastic syndromes (MDS) are hematopoietic stem cell malignancies. Known predisposing factors to adult MDS include rare germline mutations, cytotoxic therapy, age-related clonal hematopoiesis, and autoimmune or chronic inflammatory disorders. To date, no published studies characterizing MDS-a...
Main Authors: | McGraw, KL, Cheng, C-H, Chen, YA, Hou, H-A, Nilsson, B, Genovese, G, Cluzeau, T, Pellagatti, A, Przychodzen, BP, Mallo, M, Arenillas, L, Mohamedali, A, Adès, L, Sallman, DA, Padron, E, Sokol, L, Moreilhon, C, Raynaud, S, Tien, H-F, Boultwood, J, Ebert, BL, Sole, F, Fenaux, P, Mufti, GJ, Maciejewski, JP |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Hematology
2019
|
Similar Items
-
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
by: Jerez, A, et al.
Published: (2012) -
Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Thomas Cluzeau, et al.
Published: (2021-09-01) -
How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Michael Loschi, et al.
Published: (2022-09-01) -
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
by: Adema, V, et al.
Published: (2022) -
IT today /
by: McGraw-Hill Companies
Published: (2001)